InvestorsHub Logo
Followers 35
Posts 2665
Boards Moderated 0
Alias Born 06/08/2014

Re: Bouf post# 278233

Friday, 06/05/2020 8:42:00 PM

Friday, June 05, 2020 8:42:00 PM

Post# of 426330
Bouf, good questions. Let's assume for a second that it was not in the trial documents or AMRN's reply brief. Can Singer somehow work it in the rebuttal brief assuming the generics mention Mori when talking obviousness in their response brief? If not, what's to stop Singer from pointing it out at oral arguments?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News